Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 14695784)

Published in World J Gastroenterol on January 01, 2004

Authors

Ren-Yi Qin1, Ru-Liang Fang, Manoj Kumar Gupta, Zheng-Ren Liu, Da-Yu Wang, Qing Chang, Yi-Bei Chen

Author Affiliations

1: Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, Province, China. ryqin@tjh.tjmu.edu.cn

Articles cited by this

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study Group. J Clin Oncol (2003) 3.09

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut (1998) 2.47

Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol Cell Biol (2002) 1.85

Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer. Hum Gene Ther (1999) 1.77

Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci U S A (2000) 1.64

Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res (1996) 1.59

Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol (2003) 1.55

Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Am J Pathol (2003) 1.27

Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis. Proc Natl Acad Sci U S A (2002) 1.23

Mechanisms of antineoplastic action of somatostatin analogs. Proc Soc Exp Biol Med (1998) 1.20

Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci U S A (2000) 1.19

Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models. Cancer Res (2002) 1.10

sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1. J Biol Chem (1999) 1.08

Signal transduction of somatostatin receptors negatively controlling cell proliferation. J Physiol Paris (2001) 1.08

The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? Ann Oncol (2002) 1.06

Antiproliferative effect of somatostatin and analogs. Chemotherapy (2001) 1.06

Treatment of hepatocellular carcinoma with long acting somatostatin analogues. Oncol Rep (2002) 1.01

[Regulation of cell proliferation by somatostatin]. Ann Endocrinol (Paris) (2002) 0.96

Somatostatin receptors. Digestion (2000) 0.94

Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells. J Nucl Med (2001) 0.91

Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results. Br J Cancer (1999) 0.91

Expression of somatostatin receptor subtypes and growth inhibition in human exocrine pancreatic cancers. J Hepatobiliary Pancreat Surg (2000) 0.86

Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-beta. Involvement of Smad4. J Biol Chem (2001) 0.84

Inhibitory role of the somatostatin receptor SST2 on the intracrine-regulated cell proliferation induced by the 210-amino acid fibroblast growth factor-2 isoform: implication of JAK2. J Biol Chem (2003) 0.83

Somatostatin, its receptors and analogs, in lung cancer. Chemotherapy (2001) 0.83

Somatostatin receptor subtype 2 gene therapy inhibits pancreatic cancer in vitro. J Surg Res (2002) 0.82

Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid. Oncology (2001) 0.82

Chemoprevention for pancreatic cancer. Int J Gastrointest Cancer (2003) 0.79

[The somatostatin receptor family--a window against new diagnosis and therapy of cancer]. Tidsskr Nor Laegeforen (2002) 0.78

Octreotide in the management of hormone-refractory prostate cancer. Chemotherapy (2001) 0.77

Articles by these authors

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron (2013) 3.27

Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol (2006) 1.98

Uterine massage to reduce blood loss after vaginal delivery: a randomized controlled trial. Obstet Gynecol (2013) 1.96

Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol (2007) 1.84

Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet (2004) 1.78

Glycosylation site-specific analysis of clade C HIV-1 envelope proteins. J Proteome Res (2009) 1.61

Epigenetic regulation of motor neuron cell death through DNA methylation. J Neurosci (2011) 1.61

The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Exp Neurol (2009) 1.50

Tourniquet device for hemorrhage control during cesarean section of complete placenta previa pregnancies. J Obstet Gynaecol Res (2013) 1.48

Restoration of connexin26 protein level in the cochlea completely rescues hearing in a mouse model of human connexin30-linked deafness. Proc Natl Acad Sci U S A (2007) 1.44

Atoh1 directs the formation of sensory mosaics and induces cell proliferation in the postnatal mammalian cochlea in vivo. J Neurosci (2012) 1.43

Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci U S A (2009) 1.40

A novel mechanism for connexin 26 mutation linked deafness: cell death caused by leaky gap junction hemichannels. Laryngoscope (2006) 1.36

Nanopatterned textile-based wearable triboelectric nanogenerator. ACS Nano (2015) 1.34

An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug Chem (2009) 1.34

Targeted connexin26 ablation arrests postnatal development of the organ of Corti. Biochem Biophys Res Commun (2009) 1.32

Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J (2003) 1.26

Connexin30 null and conditional connexin26 null mice display distinct pattern and time course of cellular degeneration in the cochlea. J Comp Neurol (2009) 1.25

Direct interaction with Rab11a targets the epithelial Ca2+ channels TRPV5 and TRPV6 to the plasma membrane. Mol Cell Biol (2006) 1.25

Gitelman's syndrome: towards genotype-phenotype correlations? Pediatr Nephrol (2006) 1.24

An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci U S A (2006) 1.23

Tissue involution and the acute phase response. Ann N Y Acad Sci (2003) 1.21

Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models. Brain Res (2009) 1.20

Evaluation by high-resolution ultrasonography of endothelial function in brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Circ J (2002) 1.20

TBLR1 regulates the expression of nuclear hormone receptor co-repressors. BMC Cell Biol (2006) 1.14

Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol (2008) 1.14

Amnesia produced by altered release of neurotransmitters after intraamygdala injections of a protein synthesis inhibitor. Proc Natl Acad Sci U S A (2007) 1.13

GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes Infect (2003) 1.12

Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells. J Immunol (2009) 1.10

Digenic inheritance of non-syndromic deafness caused by mutations at the gap junction proteins Cx26 and Cx31. Hum Genet (2008) 1.08

Transparent flexible graphene triboelectric nanogenerators. Adv Mater (2014) 1.06

Diencephalic damage decreases hippocampal acetylcholine release during spontaneous alternation testing. Learn Mem (2003) 1.06

Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles. Infect Immun (2004) 1.06

Real-time polymerase chain reaction microRNA detection based on enzymatic stem-loop probes ligation. Anal Chem (2009) 1.06

Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5. EMBO J (2006) 1.05

The beta-glucuronidase klotho exclusively activates the epithelial Ca2+ channels TRPV5 and TRPV6. Nephrol Dial Transplant (2008) 1.05

BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals. Diabetes Care (2007) 1.03

Stat3 mediates expression of autotaxin in breast cancer. PLoS One (2011) 1.03

Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis. World J Gastroenterol (2003) 1.02

Vertical alveolar ridge augmentation with beta-tricalcium phosphate and autologous osteoblasts in canine mandible. Biomaterials (2009) 1.01

LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions. Mol Cell Proteomics (2012) 1.00

GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates. J Immunol (2010) 0.99

Expression of TREM-1 mRNA in acute pancreatitis. World J Gastroenterol (2004) 0.99

Connexin29 is highly expressed in cochlear Schwann cells, and it is required for the normal development and function of the auditory nerve of mice. J Neurosci (2006) 0.99

Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1. J Leukoc Biol (2006) 0.98

Molecular pathology in the lungs of severe acute respiratory syndrome patients. Am J Pathol (2007) 0.96

Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis. Mol Neurobiol (2011) 0.96

Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis. Eur J Pharmacol (2009) 0.95

Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses. Proc Natl Acad Sci U S A (2013) 0.95

Quantitative analysis of zeptomole microRNAs based on isothermal ramification amplification. RNA (2009) 0.95

Acetylcholine release in hippocampus and striatum during testing on a rewarded spontaneous alternation task. Neurobiol Learn Mem (2005) 0.95

Early postnatal virus inoculation into the scala media achieved extensive expression of exogenous green fluorescent protein in the inner ear and preserved auditory brainstem response thresholds. J Gene Med (2013) 0.95

Acetylcholine release in the hippocampus and striatum during place and response training. Learn Mem (2005) 0.94

VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. PLoS One (2010) 0.93

A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo. Mol Cancer Ther (2010) 0.93

Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines. World J Gastroenterol (2003) 0.93

Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication. PLoS One (2008) 0.93

Proteins with altered levels in plasma from glioblastoma patients as revealed by iTRAQ-based quantitative proteomic analysis. PLoS One (2012) 0.93

Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis. Clin Cancer Res (2005) 0.92

Paracrine role for mesenchymal stem cells in acute myocardial infarction. Biol Pharm Bull (2009) 0.92

Chronic traumatic pseudoaneurysm of the ascending aorta causing right ventricular inflow obstruction. Circ J (2003) 0.92

Anti-angiogenic effects of somatostatin receptor subtype 2 on human pancreatic cancer xenografts. Carcinogenesis (2004) 0.92

Highly stretchable piezoelectric-pyroelectric hybrid nanogenerator. Adv Mater (2013) 0.92

Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor. Hum Pathol (2005) 0.91

Overlapping and distinct roles for PI3Kbeta and gamma isoforms in S1P-induced migration of human and mouse endothelial cells. Cardiovasc Res (2008) 0.91

IgG gene expression and its possible significance in prostate cancers. Prostate (2011) 0.90

Different functional consequences of two missense mutations in the GJB2 gene associated with non-syndromic hearing loss. Hum Mutat (2009) 0.90

Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication. Virology (2012) 0.90

Melatonin-mediated cytoprotection against hyperglycemic injury in Müller cells. PLoS One (2012) 0.90

Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol (2003) 0.89

Establishment of a knock-in mouse model with the SLC26A4 c.919-2A>G mutation and characterization of its pathology. PLoS One (2011) 0.89

Characterization of an immunodominant antigenic site on GB virus C glycoprotein E2 that is involved in cell binding. J Virol (2006) 0.89

Hydrophobic sponge structure-based triboelectric nanogenerator. Adv Mater (2014) 0.88

Intra-amygdala injections of CREB antisense impair inhibitory avoidance memory: role of norepinephrine and acetylcholine. Learn Mem (2008) 0.88

An approach to histology-based diagnosis and treatment of Madura foot. J Infect Dev Ctries (2012) 0.87

ERK1/2 signaling pathways involved in VEGF release in diabetic rat retina. Invest Ophthalmol Vis Sci (2010) 0.87

Protection of spiral ganglion neurons from degeneration using small-molecule TrkB receptor agonists. J Neurosci (2013) 0.87

Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication. J Infect Dis (2008) 0.86

Compartmentalized, functional role of angiogenin during spotted fever group rickettsia-induced endothelial barrier dysfunction: evidence of possible mediation by host tRNA-derived small noncoding RNAs. BMC Infect Dis (2013) 0.86

The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma. Oncol Res (2012) 0.86

Functional evaluation of GJB2 variants in nonsyndromic hearing loss. Mol Med (2011) 0.85

Engraftment of quiescent progenitors and conversion to full chimerism after nonmyelosuppressive conditioning and hematopoietic cell transplantation in miniature swine. Biol Blood Marrow Transplant (2003) 0.85

Effects of HMG on revascularization and follicular survival in heterotopic autotransplants of mouse ovarian tissue. Reprod Biomed Online (2012) 0.85

GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation. J Interferon Cytokine Res (2005) 0.85

Occurrence of extended spectrum beta-lactamases producing alpha hemolytic Escherichia coli in neonatal diarrhea. Pak J Biol Sci (2014) 0.85

Age-related memory impairments due to reduced blood glucose responses to epinephrine. Neurobiol Aging (2009) 0.85

Chlorophyll reduction in the seed of Brassica napus with a glutamate 1-semialdehyde aminotransferase antisense gene. Plant Mol Biol (2003) 0.84

7,8,3'-Trihydroxyflavone, a potent small molecule TrkB receptor agonist, protects spiral ganglion neurons from degeneration both in vitro and in vivo. Biochem Biophys Res Commun (2012) 0.84

[Streptozotocin induction of type 2 diabetes in tree shrew]. Dongwuxue Yanjiu (2013) 0.84

South African GB virus C isolates: interactions between genotypes 1 and 5 isolates and HIV. J Infect Dis (2005) 0.84

Geometrical and electronic rules in fullerene-based compounds. Chem Asian J (2011) 0.84

Growth factors and platelet-rich plasma: promising biological strategies for early intervertebral disc degeneration. Int Orthop (2015) 0.83

Expression of a Brassic napus glutamate 1-semialdehyde aminotransferase in Escherichia coli and characterization of the recombinant protein. Protein Expr Purif (2003) 0.83

Glioblastoma cell secretome: analysis of three glioblastoma cell lines reveal 148 non-redundant proteins. J Proteomics (2011) 0.83

Multidrug resistant pathogenic Escherichia coli status in water sources and Yamuna River in and around Mathura, India. Pak J Biol Sci (2014) 0.83

Early developmental expression of connexin26 in the cochlea contributes to its dominate functional role in the cochlear gap junctions. Biochem Biophys Res Commun (2011) 0.83

Mechanisms of inhibition of growth of human pancreatic carcinoma implanted in nude mice by somatostatin receptor subtype 2. Pancreas (2004) 0.83

Modulation and effects of surface groups on photoluminescence and photocatalytic activity of carbon dots. Nanoscale (2013) 0.83